methotrexate versus dexamethasone iontophoresis in palmoplantar psoriasis
Phase 1
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/05/067768
- Lead Sponsor
- Dr DesinghK
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Bilateral palmoplantar psoriasis not on systemic immunosupressants.
2.Patients who are not desirous of conception during study period.
3.Age 20 yrs – 60 yrs
4.Both sexes
5.Patient willing for regular follow up
Exclusion Criteria
1.Patient not willing to participate in the study.
2.Pregnant and lactating women
3.Haematological & hepatic disorder patients.
Patients with pacemaker, metallic intrauterine device.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method improvement in the modified PASI Score after 8 weeks of treatmentTimepoint: baseline, 4 weeks, 8 weeks
- Secondary Outcome Measures
Name Time Method To assess whether dexamethasone sodium phosphate iontophoresis is an effective local therapy for psoriasis. <br/ ><br>Timepoint: 2 months